Delivery Order SPE2DB20D3303-SPE2DB25FA1ME
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $9,356.16 to provide ABILIFY MAINTENA ER 400 MG VLS medical products. The award was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 7, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,382.47 Firm Fixed Price Delivery Order contract is for the supply of ABILIFY MAINTENA ER 300 MG VLS, a specialty medication. The contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of ABILIFY MAINTENA ER 400 MG VLS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,885.77 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,843.01 delivery order contract is for the provision of ABILIFY MAINTENA ER 400 MG VLS, a pharmaceutical product. The contract is not designated as a set-aside and is for a firm fixed price. The award has an ultimate completion date of April 23, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Abilify Maintena ER 400 mg vials. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with an ultimate completion date of August 23, 2024 and a ceiling value of $2,471.47. The contract does not have a set-aside designation. Amerisourcebergen, through its Corporate Office Division, has been a long-standing supplier of...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,412.67, is for the delivery of ABILIFY MAINTENA ER 300 MG SYRS, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,647.00, for the delivery of ABILIFY MAINTENA ER 300 MG VLS pharmaceutical products. The contract has a period of performance extending through June 23, 2025. Amerisourcebergen Drug Corp is also the holder of a larger Indefinite Delivery...
- This federal contract award, valued at $1,735.67, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of ABILIFY MAINTENA ER 300 MG VLS, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,568.80, is for the supply of ABILIFY MAINTENA ER 400 MG VLS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of ABILIFY MAINTENA ER 400 MG SYRS, a specialty pharmaceutical product. The contract has a ceiling value of $23,709.13 and an ultimate completion date of August 5, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated....
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA1MEDelivery Order
This federal contract award is for the pharmaceutical product ABILIFY MAINTENA ER 400 MG SYRS. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price of $1,842.17 and an Ultimate Completion Date of July 18, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and running through December 2026. This IDC serves as a comprehensive global pharmaceutical support vehicle, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/17/25 |